SAM #75H70927BAO-009

Sole-source Cepheid molecular testing systems, module activation, and support for Fort Peck Service Unit

The Billings Area Indian Health Service plans a noncompetitive Cepheid procurement for molecular testing equipment and related work at the Fort Peck Service Unit. - Procurement approach: Intended sole-source, fixed-price purchase from Cepheid; this notice is not a request for competitive proposals. - Equipment: Two new Cepheid moderate-complexity molecular testing systems, including required hardware, software, licenses, cables, and accessories. Systems must support FDA-cleared STI assays and work with existing laboratory infrastructure. - Existing instruments: Activate and verify four currently inactive modules across two existing Cepheid instruments. The notice also describes additional modules, but does not specify models, part numbers, or a quantity for module hardware. - Services and requirements: Installation and configuration, operational and software-communication checks, operator training, documentation, warranty, and technical-support information. The SOW requires delivery within 30 calendar days of award; related services follow delivery. - OEM rationale: The notice identifies Cepheid as the sole manufacturer of Xpert reagents and GeneXpert systems and the only authorized U.S. service provider for GeneXpert systems. - Performance dates: The notice gives a period of December 1, 2026, through November 30, 2027. Equipment delivery is separately due within 30 calendar days after award; warranty begins upon Government acceptance. - Details not provided: No contract value, system models, part numbers, or specific module-hardware quantity is stated.

Description

The Billings Area Indian Health Services intends to award a non-competitive, sole source contract to Cepheid, US904 Caribbean Dr., Sunnyvale, CA under the authority of FAR 12.102(a), Restricting Competition. Fort Peck Service Unit currently utilizes the Cepheid XVI systems, and Cepheid is the sole manufacturer of Xpert® reagents, and GeneXpert® systems are manufactured exclusively for Cepheid. Xpert reagent test cartridges are designed and manufactured to only be used with Cepheid’s instruments. Cepheid is currently the only authorized provider of service for GeneXpert systems to customers within the United States. The company shall provide additional Cepheid modules to our current owned system along with service agreements. The procurement will be conducted pursuant to the authority of Federal Acquisition Regulation FAR 12.102(a), Restricting Competition. IHS anticipates the award of a fixed-price purchase order for the period of December 1, 2026, through November 30, 2027. This is not a request for competitive proposal and no solicitation is available. Firms that believe they can provide the equipment, and services are encouraged to identify themselves and give written notification within the timeframe specified in the original notice by November 6, 2026. A determination by the Government not to complete this action is within the discretion of the Government. Information received will be considered solely for the purpose of future considerations

View original listing